On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.
On today's podcast, host Wayne Bowden joins Biorasi's Omar Ibrahim and IBM Watson Health HOPE team members Dr. Mehool Patel and Dr. Dilhan Weeraratne...
"I think all disciplines go through a process, a journey of being imagined and then becoming a science and then becoming a discipline of...
"Patients have already been exposed to these large language models (LLMs). Yes, they are aware of the risks, but they are also very aware...